中國軟件國際(00354.HK)獲控股股東、主席陳宇紅增持100萬股
格隆匯9月1日丨中國軟件國際(00354.HK)公吿,於2021年9月1日,公司獲接其控股股東、主席兼執行董事陳宇紅博士通知,指其已於2021年9月1日在公開市場收購合共100萬股公司普通股,有關平均價格約為每股股份13.09港元,有關總金額約為1309萬港元。根據股權增加所收購的普通股總數相當於公司於本公佈日期已發行股份總數0.03%。
於緊隨股權增加後,陳博士持有3.78億股股份,相當於公司於本公佈日期已發行股份總數約13.03%,其中1.16億股股份(相當於約3.98%)乃根據《證券及期貨條例》第317條須予披露的協議由其他一致行動人士持有。股權增加反映陳博士對公司的目前及長遠發展及業務增長充滿信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.